Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Endocrinology|September 18, 2025
Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)Lynnette K Nieman, Marco Boscaro, Carla Scaroni, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.
The Lancet. Oncology|October 2, 2025
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort studyMingzhao Xing, Shuhuang Lin, Aarti Mathur, et al.
Endocrine-Related Cancer|January 18, 2015
A registry-based study of thyroid paraganglioma: histological and genetic characteristicsErnst von Dobschuetz, Helena Leijon, Camilla Schalin-Jäntti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Association between BRAF V600E mutation and recurrence of papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
JAMA|April 11, 2013
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
The New England Journal of Medicine|May 4, 2012
Combination chemotherapy in advanced adrenocortical carcinomaMartin Fassnacht, Massimo Terzolo, Bruno Allolio, et al.
Endocrine Connections|May 7, 2020
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studyLouise Vølund Larsen, Delphine Mirebeau-Prunier, Tsuneo Imai, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2007
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1Birke Bausch, Wiktor Borozdin, Victor F Mautner, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Pageof 15